Stay updated on NEOMUN Trial: Anti-PD-1 in Resectable Lung Cancer
Sign up to get notified when there's something new on the NEOMUN Trial: Anti-PD-1 in Resectable Lung Cancer page.

Latest updates to the NEOMUN Trial: Anti-PD-1 in Resectable Lung Cancer page
- Check6 days agoChange DetectedA site-wide notice about a lapse in government funding and the NIH Clinical Center's operating status was added, and the page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check13 days agoChange DetectedMinor UI text updates include a Show glossary option, capitalization changes to labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data), and a new Revision: v3.4.0 replacing v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4; no substantive changes to the study details or content.SummaryDifference0.1%

- Check48 days agoChange DetectedFooter updates include adding Revision: v3.3.3 and removing HHS Vulnerability Disclosure and Revision: v3.3.2 from the page footer.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2, indicating a minor version bump with no visible user-facing content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check77 days agoChange DetectedAdded a note that PubMed publications are auto-filled and may not relate to the study, and updated the revision label from v3.2.0 to v3.3.1.SummaryDifference0.1%

Stay in the know with updates to NEOMUN Trial: Anti-PD-1 in Resectable Lung Cancer
Enter your email address, and we'll notify you when there's something new on the NEOMUN Trial: Anti-PD-1 in Resectable Lung Cancer page.